<DOC>
	<DOCNO>NCT02274272</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety probiotic ADR-1/GMNL-263 capsule ( Lactobacillus reuteri ADR-1/ Lactobacillus reuteri GMNL-263 ) treatment adult type2 DM .</brief_summary>
	<brief_title>Effects Genmont Probiotic Improve Level Blood Glucose Other Diabetic Associate Parameter Type 2 Diabetes Patients</brief_title>
	<detailed_description>Background：Based animal study , intake probiotic bacteria suggest improve insulin sensitivity reduce inflammation . Objective ： The objective study determine effect supplementation probiotic strain Lactobacillus reuteri ADR-1 ( ADR-1 ) Lactobacillus reuteri GMNL-263 ( GMNL-263 ) six month metabolic profile , intestinal microbiota profile biomarkers inflammation type 2 diabetes patent . Methods ： This randomized double-blind placebo-controlled clinical trial perform 120 diabetic patient . Subjects divide 3 group : 40 subject group A receive placebo , 40 subject group B receive ADR-1 ( 4 x 109 colony-forming units/d ) , 40 subject group C receive GMNL-263 . ( 2 x 1010 cells/d ) 6 month . Fasting blood sample take baseline intervention measure metabolic profile biomarkers inflammation include C reactive protein ( CRP ) , Interleukin 6 ( IL-6 ) Tumor necrosis factor-alpha ( TNF-α ) . The intestinal microbiota profile detect stool sample real-time polymerase chain reaction ( RT-PCR ) .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Type 2 diabetes duration &gt; 6 month 2 . 7 % &lt; HbA1c ≦ 10 % 3 . Adults 25 70 year age 4 . BMI &gt; 18.5 1 . Pregnancy 2 . Subjects serious disease cancer ( patient benign tumor medical control rule ) , kidney failure / dialysis , heart disease , stroke . 3 . Autoimmune Disease 4 . Administration healthy food diabetes 4 week inclusion 5 . Administration probiotic 4 week inclusion 6 . Administration antibiotic 4 week inclusion 7 . Participation clinical trial 8 . ALT/SGPT AST/SGOT &gt; 3x upper limit normal ( ULN ) 9. eGFR &lt; 30mL/min/1.73m2 10 . Subjects lack physical integrity gastrointestinal tract , malabsorption syndrome , inability take oral medication .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>lactobacillus reuteri</keyword>
	<keyword>type 2 diabetes</keyword>
</DOC>